SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs informs about acquisition

04 Feb 2025 Evaluate
With reference to the query raised by BSE through email dated February 4, 2025 regarding ‘Date of Share Subscription and Shareholders’ Agreement not given.’ with respect to announcement bearing reference no. ADL/SE/2024-25/127 dated February 3, 2025, Aarti Drugs has submitted the revised disclosure in line with query raised by BSE. The Company has on Monday, February 3, 2025, entered into a ‘Share Subscription and Shareholders’ Agreement’ with ‘Prozeal Green Power Private Limited’ and ‘Pro-Zeal Green Power Nine Private Limited’. This transaction entails acquisition of 26.25% Equity Shares/ Voting Rights and Compulsory Convertible Debentures by the Company in ‘Pro-Zeal Green Power Nine Private Limited’- a Special Purpose Vehicle (SPV) formed for developing, constructing, operating and maintaining a 24.40 MWp (19.36 MW) solar power plant exclusively to cater the Company’s power requirement partly. This is in line with the Company’s commitment towards procuring power through renewable resources. The detailed disclosures as required under SEBI Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

388.45 -9.30 (-2.34%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×